Development of a Novel Therapeutic Strategy Using Nucleic Acid Aptamers for Interstitial Cystitis (Hanna Type), a Designated Intractable Disease
--Proved therapeutic efficacy of interferon-γ suppression in a disease model
Kanazawa University Institute of Medical, Pharmaceutical and Health Sciences Faculty of Medicine Daichi Maeda, Department of Molecular Cytopathology, Professor, Lecturers Yoshiyuki Akiyama, Department of Urology and Male Medicine, University of Tokyo, University Hospital, Haruki Kume, Department of Urology and Male Medicine, Professor, Yukio Honma, Department of Interstitial Cystitis Medicine, Kyorin University School of Medicine, Professor, Luo Yi, Department of Urology, University of Iowa [...].
登録日:2023-12-28